Predictors of outcome in dogs with subcutaneous or intramuscular hemangiosarcoma

Journal of the American Veterinary Medical Association

Volumn 238, Issue 4, 2011, Pages 472-479

  Shiu, Kai Biu ^a   Flory, Andrea B ^b   Anderson, Christie L ^b   Wypij, Jackie ^c   Saba, Corey ^d   Wilson, Heather ^e   Kurzman, Ilene ^f   Chun, Ruthanne ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b ANIMAL MEDICAL CENTER   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

^f TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSARCOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DOG; DOG DISEASE; FEMALE; MALE; MULTICENTER STUDY; PATHOLOGY; RETROSPECTIVE STUDY; SOFT TISSUE TUMOR; TREATMENT OUTCOME;

ANIMALS; COHORT STUDIES; DOG DISEASES; DOGS; FEMALE; HEMANGIOSARCOMA; MALE; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 79951818740     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.238.4.472     Document Type: Article

References (28)

1. Brown NO, Patnaik AK, MacEwen EG. Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 1985;186:56-58.
2. Hammer AS, Couto CG, Filppi J, et al. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 1991;5:160-166.
3. Ogilvie GK, Powers BE, Mallinckrodt CH, et al. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 1996;10:379-384. (Pubitemid 126701157)
4. Prymak C, McKee LJ, Goldschmidt MH, et al. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 1988;193:706-712.
5. Vail DM, MacEwen EG, Kurzman ID, et al. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: A randomized multi-institutional clinical trial. Clin Cancer Res 1995;1:1165-1170.
6. Wood CA, Moore AS, Gliatto JM, et al. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993). J Am Anim Hosp Assoc 1998;34:417-421. (Pubitemid 128516197)
7. Hargis AM, Ihrke PJ, Spangler WL, et al. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Vet Pathol 1992;29:316-328.
8. Ward H, Fox LE, Calderwood-Mays MB, et al. Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. J Vet Intern Med 1994;8:345-348.
9. Bulakowski EJ, Philibert JC, Siegel S, et al. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006). J Am Vet Med Assoc 2008;233:122-128.
10. Sorenmo KU, Jeglum KA, Helfand SC. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J Vet Intern Med 1993;7:370-376.
11. Bar-Am Y, Anug AM, Shahar R. Femoral compartment syndrome due to haemangiosarcoma in the semimembranosus muscle in a dog. J Small Anim Pract 2006;47:286-289.
12. Aird B. Clinical and hematologic manifestations of anemia. In: Bernard F, Feldman JGZ, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Hagerstown, Md: Lippincott Williams & Wilkins, 2000;140-142.
13. Rebar AH, Hahn FF, Halliwell WH, et al. Microangiopathic hemolytic anemia associated with radiation-induced hemangiosarcomas. Vet Pathol 1980;17:443-454. (Pubitemid 10011418)
14. Kim SE, Liptak JM, Gall TT, et al. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997- 2004). J Am Vet Med Assoc 2007;231:1550-1557. (Pubitemid 350305151)
15. Schultze AE. Interpretation of canine leukocyte responses. In: Bernard F, Feldman JGZ, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Hagerstown, Md: Lippincott Williams & Wilkins, 2000;366-381.
16. Hammer AS, Couto CG, Swardson C, et al. Hemostatic abnormalities in dogs with hemangiosarcoma. J Vet Intern Med 1991;5:11-14.
17. Schultheiss PC. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest 2004;16:522-526. (Pubitemid 39527179)
18. Yamagami T, Kobayashi T, Takahashi K, et al. Prognosis for canine malignant mammary tumors based on TNM and histologic classification. J Vet Med Sci 1996;58:1079-1083. (Pubitemid 126478412)
19. Vail DM, Withrow SJ, Schwarz PD. Perianal adenocarcinoma in the canine male: a retrospective study of 41 cases. J Am Anim Hosp Assoc 1990;26:329-334.
20. Hahn KA, DeNicola DB, Richardson RC, et al. Canine oral malignant melanoma: prognostic utility of an alternative staging system. J Small Anim Pract 1994;35:251-256.
21. MacEwen EG, Patnaik AK, Harvey HJ, et al. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum. Cancer Invest 1986;4:397-402. (Pubitemid 17016050)
22. Polton GA, Brearley MJ. Clinical stage, therapy, and prognosis in canine anal sac gland carcinoma. J Vet Intern Med 2007;21:274-280. (Pubitemid 46512676)
23. Bostock DE, Crocker J, Harris K, et al. Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours. Br J Cancer 1989;59:915-918. (Pubitemid 19155707)
24. Scase TJ, Edwards D, Miller J, et al. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med 2006;20:151-158. (Pubitemid 43219385)
25. Seguin B, Besancon MF, McCallan JL, et al. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002). J Vet Intern Med 2006;20:933-940. (Pubitemid 44338057)
26. Kuntz CA, Dernell WS, Powers BE, et al. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J Am Vet Med Assoc 1997;211:1147-1151. (Pubitemid 127470920)
27. Cross SS, Start RD. Estimating mitotic activity in tumours. Histopathology 1996;29:485-488. (Pubitemid 26384187)
28. Hillers KR, Lana SE, Fuller CR, et al. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. J Am Anim Hosp Assoc 2007;43:187-192. (Pubitemid 47099156)